Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
Articolo
Data di Pubblicazione:
2022
Citazione:
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial / Mebazaa, Alexandre; Davison, Beth; Chioncel, Ovidiu; Cohen-Solal, Alain; Diaz, Rafael; Filippatos, Gerasimos; Metra, Marco; Ponikowski, Piotr; Sliwa, Karen; Voors, Adriaan A; Edwards, Christopher; Novosadova, Maria; Takagi, Koji; Damasceno, Albertino; Saidu, Hadiza; Gayat, Etienne; Pang, Peter S; Celutkiene, Jelena; Cotter, Gad. - In: THE LANCET. - ISSN 0140-6736. - (2022). [10.1016/S0140-6736(22)02076-1]
Abstract:
There is a paucity of evidence for dose and pace of up-titration of guideline-directed medical therapies after admission to hospital for acute heart failure.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Mebazaa, Alexandre; Davison, Beth; Chioncel, Ovidiu; Cohen-Solal, Alain; Diaz, Rafael; Filippatos, Gerasimos; Metra, Marco; Ponikowski, Piotr; Sliwa, Karen; Voors, Adriaan A; Edwards, Christopher; Novosadova, Maria; Takagi, Koji; Damasceno, Albertino; Saidu, Hadiza; Gayat, Etienne; Pang, Peter S; Celutkiene, Jelena; Cotter, Gad
Link alla scheda completa:
Pubblicato in: